People who develop multiple sclerosis (MS) at age 50 or later are more likely to accumulate disability through mechanisms that are not directly linked to relapses or MRI activity than those with earlier-onset disease, according to an Italian registry study. “This suggests that the adverse prognostic effect of [late-onset…
Discussion
They say drowning is quieter than people expect. It rarely looks like the thrashing and shouting we picture from movies. More often it is silent, and the people standing right there don’t realize it’s happening until it’s too late. Lately, I’ve come to understand that caregiving can feel the same…
Discussion
An international trial will test a combined approach to targeting underrecognized cognitive symptoms of multiple sclerosis (MS), coaching patients on becoming more conscientious with the aim of making them more likely to stick with treatment plans. Difficulties with learning, memory, and related functions are among the symptoms of MS, affecting…
Discussion
Scientists have identified six proteins that could serve as targets for new treatments designed to slow multiple sclerosis (MS) progression. The data showed that one protein, RRM2B, may interact with the approved MS treatment Mavenclad (cladribine), while the other proteins interacted with molecules that are not currently used…
Discussion
On June 17, 2006 — 20 years ago yesterday — I had my closest call as a Special Forces medic, and the first mass casualty situation I was ever involved in. Sometime afterward, a teammate observed, “You didn’t even hesitate! You just ran out on the street and did first-aid…
Get regular updates to your inbox.
